Adverse Effect of Antipyretic Agent on Serum Zinc*
|
|
- Reginald Charles
- 5 years ago
- Views:
Transcription
1 ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vl. 23, N. 2 Cpyright 1993, Institute fr Clinical Science, Inc. Adverse Effect f Antipyretic Agent n Serum Zinc* SIN ICI SOJI, Ph.D, M.D.,t ID EO MIYAMOTO, M.D.,i and SOZO NOMOTO, Ph.D.'1 Departments f Medicine, f and Surgery,t Schl f Medicine, and Divisin f Clinical Chemistry, Schl f Medical TechnlgyJ1 Shinshu University, Matsumt, 390, Japan ABSTRACT T study the pathgenesis f the inc deficiency that is smetimes fund pstperatively, the serum cncentratin f inc was determ ined in 35 patients befre, during, and after thracabdminal surgery. Preperatively, a serum inc level belw 60 jig per 100 ml was recrded in fur f 16 patients tested and was assciated w ith severe anrexia. Pstperatively, the serum inc level was significantly reduced fr up t fur days, when the patient was unable t eat. After the start f ral feeding, the average serum inc level returned t nrmal. The serum inc level decreased rapidly in tw patients after buts f severe sweating prduced by an antipyretic agent (diclfenac). In anther patient, the serum inc level decreased rapidly fllwing the lss f a large vlume f intestinal fluid via an intestinal stma. Factrs leading t lw serum cncentratins f inc thus include anrexia, peratins, antipyretic agents, and the lss f intestinal fluid. Intrductin Zinc, an essential elem ent, has been reprted t be depleted in patients fllwing surgery.1,3,4 This study was cnducted t investigate the alteratins in serum inc level fllw ing thracab * Send reprint requests t: Shin ichi Shji, Ph.D., M.D., Department f Neurlgy, Institute f Clinical Medicine, University f Tsukuba, Tennhdai, Tsukuba, 305, Japan. Dr.. Miyamt s present address: Divisin f Surgery, kushin General spital, Nishi, Nakan, 383, Japan. dm inal surgery and t evaluate the pathgenesis f the lw serum inc level that may exist during the pstperative perid. Subjects and M ethds A ttal f 35 patients, 27 m en and eight wmen, aged frm 41 t 81 years, participated in this study. Each was scheduled fr a thracabdm inal peratin, including surgery n the esphagus (7), stmach (7), small intestine (1), cln and rectum (3), biliary tract and gall bladder (5), /93/ $00.90 Institute fr Clinical Science, Inc.
2 ADVERSE EFFECT OF ANTIPYRETIC AGENT ON SERUM ZINC 107 jig/100ml 100 t * < Z w u : 3 V. 50 F ig u r e 1. Serum cncentratin f inc in surgical patients during the p st p erativ e perid, b efre resum ing ral feeding. Black circles and bars represent mean ± standard deviatin (SD). N represents the number f patients. Prep. refers t th e p r e p e r a tiv e perid. The 1-2,3-4,5-8, and 9-20 days refers t thse pstperative days. *Indicates a statistically significant d ifferen ce frm the mean preperative value fr serum inc (p < 0.001). Nrmal value fr serum inc: 80.4 ± 3.3 jig per 100 ml (66.7 t 87.9 jig per 100 ml). pre p days pstp. liver (9), and pancreas (3), including m alignant disease. T he serum inc cncentratin was determ in ed preperatively (18 ccasins) and pstperatively: (a) befre resum ptin f eating (41 ccasins) and (b) fllwing resum ptin f eating (47 ccasins). Sixty-seven healthy adults, 35 m en and 32 w m en, p a rticip a te d as nrmal cntrls. B ld sam ples w ere c lle cte d by venus puncture using a inc free evacuated plastic tu b e. Im m ediately after drawing bld, the tubes were allwed t stand fr 30 min. until the cltting was cm pleted. T hen the serum was separated by centrifugatin. Serum samples w ere discarded if any hem lysis was bserved. Atmic absrptin spectrphtmetry f serum inc was perfrm ed by the m ethd f Nmt.6 The samples were deprteinied w ith hydrchlric acid and trichlracetic acid. The prtein free extracts were subjected t analysis f inc with use f M del Z-8000 flame type atmic absrptin spectrmeter.* T h e s ig n ific a n c e f d iffe re n c e s betw een means was determ ined by Student s t-test. A level f p < 0.05 was accepted as statistically significant. Results Reference interval fr serum inc level was frm 66.7 t 87.9 ig per 100 ml and the average ± SD was 80.4 ± 3.3 jig per 100 ml. Preperatively, fur f the 16 patients exhib ited lw levels f serum inc, being; 43, 45, 49, and 58 xg per 100 ml. All fur patients had severe anrexia withut preperative inc supplem ents, wing (in ne case each) t chlecystitis * itachi Crp., Japan.
3 108 SOJI, MIYAMOTO, AND NOMOTO with chlelithiasis, carcinma f the gall bladder, gastric carcinma, and esphaggastric carcinma. Pstperatively, befre the patients resum ed ral feeding, the serum inc level was significantly lwer than that during the preperative perid (figure 1). T h is w as ra te d fr up t fur days pstperatively. T w i n t e r e s t i n g p a tie n ts w e re bserved t develp lw serum levels f inc re la te d t fev er and sw eatin g induced by diclfenac, while ne patient exhibited this finding related t the lss f intestinal fluid. Case Reprts A 66-year-ld man with acute chlecystitis with chlelithiasis exhibited a rapid decline in serum inc frm 72 t 35 (ig per 100 ml within ne week pstperatively, even thugh he was taking fd by muth. During this perid, he had a high fever and received diclfenac sdium, an antipyretic agent, by the rectal rute. Such treatment was fllwed by prfuse sweating (figure 2), thught t have been a pssible factr in the decline in serum inc level. A 68-year-ld wman wh was perated n fr chlangicarcinma, develped a hepatic abscess pstperatively. She had a fever, and was repeatedly treated with diclfenac by the rectal rute. The serum inc level shwed a relatively rapid drp n tw ccasins; the first was frm 61 t 43 jig per 100 ml within 10 days. N inc supplements were administered during the 9 days f this 10-day perid. A secnd drp in serum inc level, frm 69 t 42 jxg per 100 ml, was bserved in the next 26 days, fllwed by an additinal decline t 30 jig per 100 ml ver the next 14 days. During the latter part f this perid, n inc supplem ent was given (figure 3). A 56-year-ld man wh had been perated n fr a rectal carcinma had a secnd peratin, this time fr ileus. Pstperatively, during the perid he was unable t take fd by muth, his serum inc level shwed a rapid drp frm 77 t 36 xg per 100 ml within 16 days, despite the daily administratin f an intravenus inc supplement (1.3 mg per day). wever, during this perid he lst a ttal vlume f 2,680 ml f intestinal fluid via an intestinal stma (figure 4). 39 C' ZBL.*,V, (3,9mg X Iday) ORAL INTAKE w s» < C3 PU SB Ed >* a ffl Serum inc le v e l (pg/100ml) F i g u r e 2. Pstperative curse f a 66-year-ld man with acute chlecystitis and chlelithiasis. e received 3.9 mg f inc intravenusly n secnd pstperative day. e began the ral intake f fd and water n the furth pstperative day. The X refers t 25 mg f diclfenac sdium, an antipyretic agent, administered by the rectal rute. Serum inc levels were 34, 72, and 35 jig per 100 ml n the 3rd, 18th, and 25th pstperative days, respectively.
4 ADVERSE EFFECT OF ANTIPYRETIC AGENT ON SERUM ZINC 109 ORAL INTAKE ZINC I.V. (1.3mg/dav X 3»d«vs) Serum in c le v e l (fig/100ml) FIGURE 3. Curse f a 68-year-ld wman fllwing peratin fr chlangicarcinma cmplicated by liver abscess. During this time, the patient tk fd and water rally, but she had persistent anrexia. Frm days 10 t 47, a supplement cntaining 1.3 mg inc was given intravenusly each day. The X refers t 25 mg f diclfenac sdium, an antipyretic agent, given by the rectal rute. Serum levels f inc were 61, 43, 69, 42, and 30 p-g per 100 ml n days 1, 11, 17, 43, and 57, respectively. Discussin T he im prtance f inc in hum an health is well dcumented. The rate f wund healing is shw n t be accelerated by a inc supplem ent.1 The bservatin that all fur patients f any patients with severe anrexia shw ed lw serum inc lev els p re p e ra tiv e ly suggests severe anrexia m ay cause inc d e ficiency judging frm serum levels even befre the peratin. Surgery r tissue injury influences inc metablism. enel et al reprted that m arked incuria ccurred in thse individuals wh had undergne majr sur- 2 INC I.V. (1.3ag/day) _> [*. < M C/5 t/3 O -1 f- Ul m l/d ay Serum in c l e v e l ( pg/100m l) F i g u r e 4. Pstperative curse f a 56-year-ld man wh develped ileus fllwing an peratin fr rectal carcinma. An intestinal stma was created in the latter prcedure. During this perid, the patient did nt take fd r water rally. e received a inc supplement given intravenusly, 1.3 mg per day, during his entire curse. Between the 26th and the 35th pstperative days, he excreted a ttal vlume f 2,680 ml f intestinal fluid thrugh the stma. Serum inc levels were 18, 64, 77, and 36 fj-g per 100 ml n the first, 13th, 20th, and 36th pstperative days, respectively.
5 110 SOJI, MIYAMOTO, AND NOMOTO gery; a decrease in their bdy inc stres was bserved pstperatively.1 Kahn et al reprted that the mean serum cncentratin f inc and f the 24 hur inc in urine were unchanged during the first pstperative week, but were elevated during the secnd pstperative week.3 L indem an e t al fund that the m ean plasm a inc level in surgical patients declined frm nrmal t lw 24 hurs pstperatively; thereafter, plasma levels rse steadily tward nrmal n the furth pstperative day.4 The present study shw ed that during the pstperative perid, while the patient was unable t take fd by muth, the serum inc level decreased significantly t abut ne-half the preperative level betw een the first and furth pstperative days. An additinal im prtant finding was that the administratin f an antipyretic agent, such as diclfenac, t febrile patients can lead t prfuse sweating and a marked lss f inc. hnadel et al cllected sw eat frm h ealth y m en and wmen during sauna bathing and fund inc levels f 500 ± 480, and 1,250 ± 770 (xg per 1, respectively. Thse investigatrs suggested that sweating is an imprtant rute fr th e excretin f inc. M cdnald et al wh analyed inc in sweat fllwing strenuus exercise, als bserved that a cnsiderable amunt f inc was lst during excessive sweating.5 The present study is the first clinical reprt t dcum ent that excessive sweating prduced by an antipyretic agent can lead t lw serum cncentratins f inc. Wlman et al reprted that abnrmal inc lss frm the gastrintestinal tract ccurred in diarrheal stl and frm the intestinal fluid that was lst thrugh suctin and fistulus discharge.7 In additin, a patient f urs was bserved with an intestinal stma wh exhibited a rapid drp in serum inc level fllwing the excretin f a large vlum e f in testinal fluid. Severe anrexia, pstperative days, usage f an antipyretic agent, and lss f intestinal fluid may cause lw serum inc level. References 1. e n e l, J.., D e W e e s e, M. S., and P r i e s, M. W. J.: Significance f magnesium and inc metablism in the surgical patient. II. Zinc. Arch. Surg. 95: , h n a d e l, D. C., S u n d e r m a n, F. W., N e c h a y, M. W., and M c N e e l y, M. D.: Atmic absrptin spectrphtmetry f nickel, cpper, inc, and lead in sweat cllected frm healthy subjects during sauna bathing. Clin. Chem. 19: , Ka h n, A. M., and G r d n,. E.: Alteratins f inc metablism fllwing surgical peratins. Surg. Gynecl. Obstet. 128:88-90, L i n d e m a n, R. D., B t t m l e y, R. G C r - NELISON, R. L., and JACOBS, L. A.: Influence f acute tissue injury n inc metablism in man. J. Lab. Clin. Med. 79: , M c D n a l d, J. T., and M a r g e n, S.: Wine versus ethanl in human nutritin. IV. Zinc balance. Am. J. Clin. Nutr. 33: , NOMOTO, S.: A simplified methd fr trace metal analysis f bilgical materials. J. UOE 9(Suppl.): , W l m a n, S. L., A n d e r s n, G.., M a r l i s s, E. B., and Je e j e e b h y, K. N.: Zinc in ttal parenteral nutritin: requirements and metablic effects. Gastrenterlgy 76: , 1979.
Biology 30S Unit Test Review: Digestion
Bilgy 30S Unit Test Review: Digestin Test utline: Multiple Chice: 10 Questins, 1 mark each. Shrt Answer: 5 Questins (answer 3 f them), 5 marks each. Lng Answer: 2 Lng Answer Questins, 10 marks each. Tasks
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationA RECENT INVESTIGATION 7 of methods for determination of ovulation suggested
The Relatin f Urine V lume t the Menstrual Cycle and Ovulatin WAYNE L. RYAN, PH.D., ROBERT J. LUBY, M.D., AND MICHAEL J. HALLER, A.B. A RECENT INVESTIGATION 7 f methds fr determinatin f vulatin suggested
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationIron and Iron Deficiency
Irn and Irn Deficiency Irn and why we need it Irn is a mineral needed by ur bdies. Irn is a part f all cells and des many things in ur bdies. Fr example, irn (as part f the prtein hemglbin) carries xygen
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationPHARYNGO-OESOPHAGECTOMY
PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationAnemia. There are three types of Anemia that effect EB patients. They are Iron Deficiency, Chronic Inflammatory and Nutritional.
Anemia Mst patients with Recessive Dystrphic Epidermlysis Bullsa are als Anemic. Anemia in EB is caused by many factrs and can becme very severe if nt treated. Anemia means nt having enugh red cells and
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationAppendix C Guidelines for treating status epilepticus in adults and children
Appendix C Guidelines fr treating status epilepticus in adults and children 1.1 Treating cnvulsive status epilepticus in adults General measures 1st stage (0 10 minutes) Secure airway and resuscitate Administer
More informationM.R.C.Path. causes to the raised plasma urea in patients admitted
Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationA Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs
A Plasma Humral Factr f Extrarenal Origin Causing Release f Reninlike Activity in Hyptensive Dgs By E. De Vit, C. Wilsn, R. E. Shipley, R. P. Miller, and B. L. Mrtx ABSTRACT Plasma reninlike activity significantly
More informationCarolina Digestive Health Associates
Carlina Digestive Health Assciates Prcedure Infrmatin Yu are scheduled fr an ERCP. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationTRANSPLANTATION AND CLINICAL IMMUNOLOGY. Proceedings of the Twenty-Second International Course, Lyon, May 1990
-----.---.----~ Reprinted frm: TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII Multiple Transplants Prceedings f the Twenty-Secnd Internatinal Curse, Lyn, 2-23 May 99 This publicatin was made pssible
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationNFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health
NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationMEDICATION GUIDE. (canagliflozin) Tablets
MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationABIOpure TM Total RNA (version 2.0)
ABIOpure TM Ttal RNA (versin 2.0) Bld Extractin Handbk Cat N: M541RP50-B FOR RESEARCH USE ONLY Table f Cntents Cntents Page Kit Cmpnents 3 Precautins 3 Stability & Strage 4 General Descriptin 4 Limitatins
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment
More informationTABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.
TABLE OF CONTENTS... Glssary f terms 2... Cde Pad Diagram 3 Understanding the Cde Pad lights.4 Cde Pad tnes 5 Fully arming the system - ON MODE 6 Fully arming the system - Quick Arm MODE 6 Partially arming
More informationM.J. Guthriel, D.G. Wagner2
EFFECT OF SUPPLEMENTAL PROTEIN OR GRAIN ON INTAKE AND UTILIZATION OF MEDIUM QUALITY PRAIRIE HAY BY STEERS M.J. Guthriel, D.G. Wagner2 and D.C. Weakley3 Stry in Brief Sixteen 1,053 lb tw-year-ld Herefrd
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More informationName of procedure: Removal of submandibular salivary gland
Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu
More informationSERUM COPPER AND ZINC IN HORMONAL CONTRACEPTIVE USERS
FERTILITY AND STERILITY Cpyright 1980 The American Fertility Sciety Vl. 33, N.3, March 1980 Printed in U.8A. SERUM COPPER AND ZINC IN HORMONAL CONTRACEPTIVE USERS KRISHNAMURTHY PREMA, M.D., M.N.A.M.S.*
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationRugby Nutrition: Achieving Body Composition Goals Practice Tips
www.bksmart.cm /BkSmart @BkSmart Rugby Nutritin: Achieving Bdy Cmpsitin Gals Practice Tips Whether yu need t increase r maintain high levels f muscle mass fr strength and pwer, and/r if yu need t lse r
More informationIf, then. Homework: Finish entire guided notes packet. Name: Pod: Date: Which variable does a scientist manipulate or control in an experiment?
Unit 1: Scientific Thinking and Inquiry 6.2B Hyptheses, Materials, Prcedure OBJECTIVE(S): Obj 1 SWBAT write a testable hypthesis that answers an investigatin s questin. Obj 2 SWBAT write a detailed materials
More informationMonensin and Extruded Urea-Grain for Range Beef Cows
Mnensin and Extruded Urea-Grain fr Range Beef Cws R. P. Lemenager, F. N. Owens, w. E. Sharp, Merwin Cmptn and Rbert Ttusek Stry in Brief Tw trials were cnducted t evaluate the supplemental value f mnensin
More information2N diploid cell replicates division - two daughter cells, each 2N division (without replication)- four daughter cells, each N (haploid)
Chrmsme - a linear DNA mlecule Hmlgus chrmsmes - chrmsmes that have the same kind f genes in the same rder 1 cpy frm father, 1 cpy frm mther humans have 46 chrmsmes with 23 hmlgus pairs als knw as sister
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationAVAILABLE COPPER, ZINC, MANGANESE AND I RON STATUS OF RAJASTHAN SOILS
Annals f Arid Zne 30 (I) : 17-21, 1991 AVAILABLE COPPER, ZINC, ANGANESE AND I RON STATUS OF RAJASTHAN SOILS R.K. EHRA and B.L. BASER Department f Sil Science & Agril. Chemistry Rajasthan Cllege f Agriculture,
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More information3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?
3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:
More informationTHROUGH 1979, immunosuppressive
Five-Year Survival After Liver Transplantatin THROUGH 1979, immunsuppressive therapy fr liver transplantatin at ur center was with aathiprine (r cyclphsphamide) and sterids, t which antilymphcyte glublin
More informationChanges in the Extracellular and Intracellular Fluid Phases of Muscle
27 I. A. PREECE AND M. SHADAKSHARASWAMY I99 2. With fi: a ratis varying frm : 1 t 1:, the actin f the tw enzymes is truly additive up t 2-25 % hydrlysis; beynd this pint it may be equal t, greater than
More informationTREATMENT OF POLYCYTHEMIA VERA
RUSSELL L. HADEN, M.D. Plycythemia vera is characterized by an increase in the number f red bld cells. This disease is insidius in rigin, chrnic, and withut pathgnmnic symptms r physical findings. Early
More informationPatterns of Cholesterol Distribution in the Participants of a Screening Project
Patterns f Chlesterl Distributin in the Participants f a Screening Prject Abdul Hamid Shaikh, S With guidelines similar t thse recmmended by the Natinal Chlesterl Educatin Prgram (NCEP), 3,3 individuals
More informationVITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.
CENTRE D ETUDE & DE VALORISATION DES ALGUES 2400 Detxificatin prperties f Apple pectin frmulatin, PROPECTIN. VITAPRO FINAL REPORT PrPectin July 2015 CENTRE D ETUDE ET DE VALORISATION DES ALGUES PRESQU
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights d nt include all the infrmatin needed t use CHIRHOSTIM safely and effectively. See full prescribing infrmatin fr CHIRHOSTIM. CHIRHOSTIM (human secretin)
More informationProcedure Information
Prcedure Infrmatin Yu are scheduled fr a Clnscpy. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING PROCEDURE: DATE: PROCEDURE TIME:
More informationCarolina Digestive Health Associates
Carlina Digestive Health Assciates Prcedure Infrmatin Yu are scheduled fr an EGD. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationMeasure Specific Guidelines for Comprehensive Diabetes Care (CDC)
Measure Specific Guidelines fr Cmprehensive Diabetes Care (CDC) Descriptin: Members age 18-75 years f age with diabetes (Type 1 and Type 2)* that had all f the fllwing: *Members in hspice are excluded
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationJapanese Rice Producers' Shift from High Yield to High Palatability and Quality -Characteristics of Highly Palatable Rice-
Jurnal f Develpments in Sustainable Agriculture 5: 96-1 (21) Japanese Rice Prducers' Shift frm High Yield t High Palatability and Quality -Characteristics f Highly Palatable Rice- Yuji Nitta* Cllege f
More informationAP Biology Lab 12: Introduction to the Scientific Method and Animal Behavior
Name: AP Bilgy Lab 12: Intrductin t the Scientific Methd and Animal Behavir Overview In this lab yu will: -Observe an rganism and design an experiment t investigate their respnses t envirnmental variables.
More informationRoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation
RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits
More informationPackage leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationMETHYL TESTOSTERONE IN PREMATURE INFANTS
METHYL TESTOSTERONE IN PREMATURE INFANTS BY URSULA JAMES and B. L. COLES Frm the General Lying-In and Annie McCall Hspitals, Lndn (RECE:IVED FOR PUBLICATiN crber 18. 195 1) It is an established fact that
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationThyroglobulin levels in serum and saliva of patients with differentiated thyroid carcinoma
Pre, Indian Acad. Sci., Vl. 87 B (Experimental Bilgy-J), N.7, July 1978. pp. 169-1". @ printed in India Thyrglbulin levels in serum and saliva f patients with differentiated thyrid carcinma D SHAH, S DANDEKAR
More informationIntravenous Fluid & Acidbase Balance for Surgical. Patients
Intravenus Fluid & Acidbase Balance fr Surgical Patients Dr. Abdullah F Alshehri, MBBS, FRCSC, MSc Assistant prfessr, cnsultant pediatric surgen What is Intravenus fluid? Why is understanding IV fluid
More informationYear 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:
Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:
More informationPROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon
PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided
More informationImplementation of G6PD testing and radical cure in P. vivax endemic countries: considerations
Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines
More informationProcedure Information
Prcedure Infrmatin Yu are scheduled fr a Clnscpy. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING PROCEDURE: DATE: PROCEDURE TIME:
More informationMEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?
MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins
More informationYear 1 MBChB Clinical Skills Session Blood Glucose Monitoring
Year 1 MBChB Clinical Skills Sessin Bld Glucse Mnitring Reviewed & ratified by: Dr V Taylr-Jnes, Cnsultant Anaesthetist Ms C Tierney, HARC Elements discussed with Ms Lesley Lamen, Diabetic Nurse Specialist
More informationThe Excretory System. 4 The Excretory System.notebook. May 24, 2017
4 The Excretry System.ntebk The Excretry System OSMOREGULATION (WATER BALANCE) Mst marine invertebrates are smcnfrmers, meaning the cncentratin f slutes in their bdy fluid is equal t that f their envirnment.
More informationUpper Endoscopy (EGD) Prep Guide
Upper Endscpy (EGD) Prep Guide Yu have been scheduled fr an Upper Endscpy (EGD). Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prcedure s that yur dctr can clearly
More informationVariation in Tissue Carnitine Concentrations with Age and Sex in the Rat
Bichem. J. (1978) 176, 677-681 Printed in Great Britain 677 Variatin in Tissue Carnitine Cncentratins with Age and Sex in the Rat By PEGGY R. BORUM Divisin fnutritin, Department fbichemistry, Vanderbilt
More informationFurther Studies on the Influence of Steroids on
INFECTION AND IMMUNITY, Aug. 1973, p. 151-155 Cpyright ( 1973 American Sciety fr Micrbilgy Vl. 8, N. 2 Printed in U.S.A. Further Studies n the Influence f Sterids n Viral Infectin in Mice D. J. GIRON,
More informationCarolina Digestive Health Associates
Carlina Digestive Health Assciates Prcedure Infrmatin Yu are scheduled fr a Clnscpy. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING
More informationARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST
ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST 7 th July 2017 Cntent 1 Intrductin 2 Tpics fr EOI in the 4 th call 3 The applicatin prcess and imprtant dates 4 Guideline fr EOIs Deadline
More informationMEDICATION GUIDE. Reference ID:
MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.
More informationdetailed in Ward and Lockhead (1970), is only summarized here.
Respnse system prcesses in abslute judgment* LAWRENCE M. WARDt and G. R. LOCKHEAD Duke University, Durham, Nrth Carlina 2778 Cnsistent relatinships are fund between Ss' abslute judgments f the value f
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationTwo Day Colonoscopy Preparation PEG (GoLYTELY) & Dulcolax Prep
Tw Day Clnscpy Preparatin PEG (GLYTELY) & Dulclax Prep Thank yu fr chsing t have yur clnscpy with NSPG Gastrenterlgy. We are delighted t be able t participate in yur healthcare and we will make every attempt
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationRuminal Availability of Phosphorus and Its Effect on Digestion
Table 2. Trial results Cncentratin f Captan,ppm liem 0 160 320 640 Dry matter digestibility (%) Ruminal 65.1 72.8 69.4 74.3 Ttal 82.1 81.9 82.4 82.0 Starch digestin (%) Ruminal 87.7 93.6 89.3 92.2 N digestibility
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationNational Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes
Natinal Hspital Inpatient Quality Reprting Measures Specificatins Manual Release Ntes Fr Manual Versin: 5.3 Cmpleted: June 15, 2017 Guidelines fr Using Release Ntes The Release Ntes prvides mdificatins
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationHealth Science Ch. 16 Cancer Lecture Outline
Cancer Leading cause f disease-related death amng peple under age 75 Secnd leading cause f death Evidence supprts that mst cancers culd be prevented by simple lifestyle changes Tbacc is respnsible fr abut
More informationCRANIOFACIAL RESECTION
CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationHIV REVERSE TRANSCRIPTION AND AZT
OVERVIEW HIV REVERSE TRANSCRIPTION AND AZT This hands-n activity is part f a series f activities and demnstratins fcusing n varius aspects f the human immundeficiency virus (HIV) life cycle. In this activity,
More information2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE
2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizatins, Clinical Cascade Breakut Sessin TB/HIV EXERCISE Created by the ICPI TB/HIV Wrkstream Abut this Handut
More informationMedication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets
Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationSummary of Findings Related to Milk Selection in Eugene School District
Crnell Unrrtnirty Charles H. Qlsn Schl f ApplÈd Estmics and Managemcnt Summary f Findings Related t Milk Selectin in Eugene Schl District Whether t include r mit chclate milk frm schl lunchrms is htly
More information